Atypical Hemolytic Uremic Syndrome (aHUS) Terminated Phase 2 Trials for Avacopan (DB15011)

Also known as: Atypical Hemolytic Uraemic Syndrome / Atypical Hemolytic-Uremic Syndrome / Atypical Hemolytic Uremic Syndrome / Hemolytic-Uremic Syndrome, Atypical / Hemolytic Uremic Syndrome, Atypical / Atypical hemolytic uremic syndrome (disorder) / Atypical haemolytic uraemic syndrome / AHUS

IndicationStatusPhase
DBCOND0061539 (Atypical Hemolytic Uremic Syndrome (aHUS))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02464891Complement Inhibition in aHUS Dialysis PatientsTreatment